Who it affects: Adults of any age can develop Quebec syndrome, but it is most common in women (approximately 60‑70 % of reported cases) and in individuals aged 20‑50 years. Some studies suggest a slightly higher incidence in people with a prior history of autoimmune disease.

Prevalence: Precise prevalence is uncertain because many cases go undiagnosed. Epidemiologic surveys in Canada estimate that 0.2‑0.4 % of the population experiences PVFS after a viral infection, translating to roughly 70,000–140,000 Canadians. In the United States, comparable rates suggest 1–2 million people may be affected annually after influenza, Epstein‑Barr virus (EBV), or SARS‑CoV‑2 infection.^[1],[2]

Symptoms

Symptoms are usually multifactorial and may fluctuate daily. They often begin within 4–6 weeks after the acute infection, but may appear later.

• Persistent fatigue – not relieved by rest, worsens with physical or mental exertion (post‑exertional malaise).
• Sleep disturbances – unrefreshing sleep, insomnia, hypersomnia.
• Cognitive dysfunction – “brain fog,” difficulty concentrating, memory lapses.
• Orthostatic intolerance – dizziness, light‑headedness, or fainting on standing.
• Muscle and joint pain – aching without swelling or inflammation.
• Headaches – tension‑type or migraine‑like.
• Sore throat & tender lymph nodes – persistent mild tenderness.
• Flu‑like symptoms – low‑grade fever, chills, or feeling “ill” without clear cause.
• Gastrointestinal issues – abdominal discomfort, nausea, bloating.
• Temperature dysregulation – feeling unusually hot or cold.
• Psychological symptoms – anxiety, depression, irritability (often secondary to chronic illness).

Symptoms must be present for at least 6 months and cause a substantial reduction in occupational, educational, or social functioning to meet diagnostic criteria.^[3]

Causes and Risk Factors

Pathophysiology

The exact cause of Quebec syndrome is not fully understood, but several mechanisms are implicated:

1. Immune dysregulation – Persistent activation of cytokines (e.g., IL‑6, TNF‑α) after viral clearance can lead to chronic inflammation.^[4]
2. Autonomic nervous system dysfunction – Impaired baroreflex and reduced vagal tone contribute to orthostatic intolerance and fatigue.
3. Neuroinflammation – Microglial activation within the central nervous system may produce the cognitive symptoms.
4. Mitochondrial abnormalities – Reduced oxidative phosphorylation efficiency, limiting cellular energy production.
5. Viral persistence or re‑activation – Low‑level viral RNA can remain in tissues, especially with EBV or human herpesvirus‑6.

Risk Factors

• Female gender
• Pre‑existing autoimmune or allergic disorders (e.g., lupus, thyroid disease)
• Severe acute viral illness (high fever, hospitalization)
• Genetic predisposition – certain HLA alleles have been associated with post‑viral fatigue.
• Psychological stress at the time of infection
• Lack of adequate rest during the acute phase

Diagnosis

There is no single laboratory test for Quebec syndrome. Diagnosis is clinical, based on a thorough history, physical exam, and exclusion of other medical conditions.

Step‑by‑step approach

1. Detailed history – Document the inciting viral infection, timeline of symptom onset, and functional impact.
2. Physical examination – Look for orthostatic vital sign changes, tender lymph nodes, and neurological signs.
3. Rule‑out investigations – Basic labs and targeted tests to exclude anemia, thyroid disease, sleep apnea, depression, and other causes.

Common tests

If red‑flag features are present (e.g., unexplained weight loss, night sweats, focal neurological deficits), further imaging such as MRI or CT may be warranted.^[5]

Treatment Options

Management is multimodal, focusing on symptom relief, functional improvement, and prevention of deconditioning.

Medication

• Pain relievers – Acetaminophen or low‑dose NSAIDs for muscle/joint aches.
• Low‑dose naltrexone (LDN) – Emerging evidence suggests it modulates immune dysregulation; consider 4.5 mg nightly.^[6]
• Modafinil or armodafinil – May improve daytime alertness in selected patients, but should be used cautiously.
• Antidepressants (SSRI/SNRI) – Helpful for comorbid depression or pain modulation.
• Beta‑blockers or fludrocortisone – For orthostatic intolerance in patients with documented POTS.

Non‑pharmacologic therapies

• Pacing & energy envelope theory – Structured activity planning to avoid post‑exertional crash.
• Graduated exercise therapy (GET) – Controversial; should be individualized and start at sub‑symptom threshold.
• Cognitive‑behavioral therapy (CBT) – Addresses maladaptive thoughts, improves coping, and can reduce disability.
• Sleep hygiene – Regular bedtime, limiting screen time, and using blackout curtains.
• Nutrition – Balanced diet rich in antioxidants; consider omega‑3 supplementation (1 g EPA/DHA daily).
• Hydration & salt – 2‑3 L water + 3–5 g salt per day for orthostatic symptoms (under physician guidance).

Procedural interventions

• None are curative. However, patients with severe dysautonomia may benefit from implantable devices (e.g., pacemaker) after cardiology evaluation.

Living with Quebec syndrome (post‑viral fatigue)

Daily management tips

• Implement a “symptom diary.” Record activity, sleep, meals, and symptom severity to identify patterns.
• Adopt a paced schedule. Break tasks into 5‑10 minute blocks with mandatory rest intervals.
• Use a mobility aid. A cane or wheelchair can conserve energy when walking long distances.
• Prioritize nutrition. Small, frequent meals prevent blood‑sugar swings that worsen fatigue.
• Mind‑body practices. Gentle yoga, tai chi, or guided meditation can improve autonomic balance.
• Social support. Join a support group (in‑person or online) to share coping strategies.
• Work accommodations. Request flexible hours, remote work, or a reduced workload under occupational health guidance.
• Regular follow‑up. Schedule 3‑monthly appointments with a primary care physician experienced in chronic fatigue.

Prevention

Because the syndrome follows an acute viral infection, primary prevention centers on reducing infection risk and ensuring adequate recovery.

• Annual influenza vaccination and up‑to‑date COVID‑19 boosters (CDC recommendations).
• Good hand hygiene, respiratory etiquette, and avoiding close contact with sick individuals.
• Prompt treatment of acute viral illnesses and adequate rest (minimum 48‑72 hours of reduced activity for moderate infections).
• Manage stress with relaxation techniques; chronic stress may predispose to immune dysregulation.
• Maintain a healthy lifestyle (balanced diet, regular moderate activity) to support immune resilience.

Complications

If untreated or poorly managed, Quebec syndrome can lead to:

• Severe deconditioning and loss of muscle mass.
• Chronic orthostatic intolerance or POTS, increasing fall risk.
• Secondary mood disorders (major depressive disorder, generalized anxiety).
• Reduced quality of life and inability to maintain employment, leading to financial strain.
• Exacerbation of comorbid conditions (e.g., irritable bowel syndrome, fibromyalgia).

When to Seek Emergency Care

References

1. Mayo Clinic. “Chronic fatigue syndrome.” Updated 2023. https://www.mayoclinic.org
2. Centers for Disease Control and Prevention. “Post‑viral fatigue syndrome.” 2022. https://www.cdc.gov
3. Fukuda K, et al. “The Chronic Fatigue Syndrome: A Comprehensive Approach.” *JAMA*. 1994;271:1498‑1505.
4. VanElzakker MB, et al. “Neuroinflammation and cytokine dysregulation in chronic fatigue syndrome.” *Nature Reviews Neurology*. 2022;18:495‑511.
5. Cleveland Clinic. “Diagnostic work‑up for chronic fatigue.” 2021. https://my.clevelandclinic.org
6. Patel K, et al. “Low‑dose naltrexone for post‑viral fatigue: A pilot study.” *Clinical Therapeutics*. 2023;45:1120‑1129.